"Disease Models, Animal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Descriptor ID |
D004195
|
| MeSH Number(s) |
C22.232 E05.598.500 E05.599.395.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Disease Models, Animal".
Below are MeSH descriptors whose meaning is more specific than "Disease Models, Animal".
This graph shows the total number of publications written about "Disease Models, Animal" by people in this website by year, and whether "Disease Models, Animal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 8 | 8 |
| 2003 | 2 | 10 | 12 |
| 2004 | 1 | 9 | 10 |
| 2005 | 4 | 17 | 21 |
| 2006 | 4 | 12 | 16 |
| 2007 | 4 | 26 | 30 |
| 2008 | 6 | 12 | 18 |
| 2009 | 3 | 11 | 14 |
| 2010 | 5 | 20 | 25 |
| 2011 | 4 | 24 | 28 |
| 2012 | 6 | 21 | 27 |
| 2013 | 5 | 18 | 23 |
| 2014 | 8 | 20 | 28 |
| 2015 | 6 | 31 | 37 |
| 2016 | 8 | 71 | 79 |
| 2017 | 76 | 726 | 802 |
| 2018 | 70 | 663 | 733 |
| 2019 | 18 | 237 | 255 |
| 2020 | 45 | 112 | 157 |
| 2021 | 15 | 108 | 123 |
To return to the timeline, click here.
Below are the most recent publications written about "Disease Models, Animal" by people in Profiles.
-
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies. Emerg Microbes Infect. 2021 Dec; 10(1):1790-1806.
-
Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2021 12 01; 21(6):569-575.
-
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine. Emerg Microbes Infect. 2021 Dec; 10(1):1598-1608.
-
Characteristics of Angiotensin I-converting enzyme 2, type II transmembrane serine protease 2 and 4 in tree shrew indicate it as a potential animal model for SARS-CoV-2 infection. Bioengineered. 2021 12; 12(1):2836-2850.
-
Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant. Emerg Microbes Infect. 2021 Dec; 10(1):1284-1292.
-
H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice. Emerg Microbes Infect. 2021 Dec; 10(1):1156-1168.
-
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection. J Clin Invest. 2021 10 15; 131(20).
-
Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice. JCI Insight. 2021 10 08; 6(19).
-
IL-6 Inhibition Reduces Neuronal Injury in a Murine Model of Ventilator-induced Lung Injury. Am J Respir Cell Mol Biol. 2021 10; 65(4):403-412.
-
S100A8 may govern hyper-inflammation in severe COVID-19. FASEB J. 2021 09; 35(9):e21798.